Preparation and in vitro and in vivo evaluations of 10-hydroxycamptothecin liposomes modified with stearyl glycyrrhetinate

References

• Cardillo TM, Govindan SV, Sharkey RM, et al. (2015). Sacituzumab govitecan (IMMU-132), an anti-trop-2/SN-38 antibody-drug conjugate: characterization and efficacy in pancreatic, gastric, and other cancers. Bioconjug Chem 26:919–31.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen C, Xiao Y, et al. (2015a). Liposomes encapsulating 10-hydroxycamptothecin-cyclodextrin complexes and their in vitro anti-tumor activities. J Nanosci Nanotechnol 15:3786–95.
   PubMed Web of Science ®Google Scholar
• Chen JD, Jiang H, Wu Y, et al. (2015b). A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation. Drug Design Develop Ther 9:2265–75.
   PubMed Web of Science ®Google Scholar
• Corvo ML, Mendo AS, Figueiredo S, et al. (2016). Liposomes as delivery system of a Sn(IV) complex for cancer therapy. Pharm Res 33:1351–8.
   PubMed Web of Science ®Google Scholar
• Darvishi B, Manoochehri S, Esfandyari‑Manesh M, et al. (2015). Enhanced cellular cytotoxicity and antibacterial activity of 18‑β‑Glycyrrhetinic Acidby Albumin‑conjugated PLGA Nanoparticles. Drug Res (Stuttg) 65:617–23.
   PubMed Web of Science ®Google Scholar
• Du Y, Zhang W, He R, et al. (2017). Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects. Bioorg Med Chem 25:3247–58.
   PubMed Web of Science ®Google Scholar
• He B, Cheng M, Chen H, et al. (2014). Optimized synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and their characteristics. Int J Nanomed 9:695–710.
   PubMed Web of Science ®Google Scholar
• He ZY, Zheng X, Wu XH, et al. (2010). Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery. Int J Pharm 397:147–54.
   PubMed Web of Science ®Google Scholar
• Huang W, Wang W, Wang P, et al. (2011). Glycyrrhetinic acid-functionalized degradable micelles as liver-targeted drug carrier. J Mater Sci Mater Med 22:853–63.
   PubMed Web of Science ®Google Scholar
• Jing C, Chen Y, Yi C, et al. (2017a). Modifying glycyrrhetinic acid liposomes with liver-targeting ligand of galactosylated derivative: preparation and evaluations. Oncotarget 8:102046–66.
   PubMedGoogle Scholar
• Jing C, Chen Y, Yi C, et al. (2017b). Glycyrrhetinic acid liposomes containing mannose-diester lauric diacid-cholesterol conjugate synthesized by lipase-catalytic acylation for liver-specific delivery. Molecules 22:1598–617.
   Web of Science ®Google Scholar
• Li Y, Liu R, Yang J, et al. (2015). Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior. Biomaterials 41:1–14.
   PubMed Web of Science ®Google Scholar
• Liu MC, Liu L, Wang XR, et al. (2016b). Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for h22 hepatocellular carcinoma both in vitro and in vivo. Int J Nanomed 11:1395–412.
   PubMed Web of Science ®Google Scholar
• Liu D, Xing J, Xiong F, et al. (2017). Preparation and in vivo safety evaluations of antileukemic homoharringtonine-loaded PEGylated liposomes. Drug Develop Commun 43:652–60.
   Google Scholar
• Liu D, Yang F, Xiong F, et al. (2016a). The smart drug delivery system and its clinical potential. Theranostics 6:1306–23.
   PubMed Web of Science ®Google Scholar
• Luo LH, Zheng PJ, Nie H, et al. (2016). Pharmacokinetics and tissue distribution of docetaxel liposome mediated by a novel galactosylated cholesterol derivatives synthesized by lipase-catalyzed esterification in non-aqueous phase. Drug Deliv 23:1282–90.
   PubMed Web of Science ®Google Scholar
• Maruyama K. (2011). Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev 63:161–9.
   PubMed Web of Science ®Google Scholar
• Min X, Heng H, Yu H, et al. (2018). Anticancer effects of 10-hydroxycamptothecin induce apoptosis of human osteosarcoma through activating caspase-3, p53 and cytochrome c pathways. Oncol Lett 15:2459–64.
   PubMed Web of Science ®Google Scholar
• Nayak D, Boxi A, Ashe S, et al. (2017). Stavudine loaded gelatin liposomes for HIV therapy: Preparation, characterization and in vitro cytotoxic evaluation. Mater Sci Eng C Mater Biol Appl 73:406–16.
   PubMed Web of Science ®Google Scholar
• Qi WW, Yu HY, Guo H, et al. (2015). Doxorubicin-Loaded Glycyrrhetinic Acid Modified Recombinant Human Serum Albumin Nanoparticles for Targeting Liver Tumor Chemotherapy. Mol Pharm 12:675–83.
   PubMed Web of Science ®Google Scholar
• Radwan MO, Ismail MAH, El-Mekkawy S, et al. (2016). Synthesis and biological activity of new 18β-glycyrrhetinic acid derivatives. Arab J Chem 9:390–9.
   Web of Science ®Google Scholar
• Sayari E, Dinarvand M, Amini M, et al. (2014). MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery. Int J Pharm 473:304–15.
   PubMed Web of Science ®Google Scholar
• Shi L, Tang C, Yin C. (2012). Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma. Biomaterials 33:7594–604.
   PubMed Web of Science ®Google Scholar
• Shi K, Tian Y, Jiang Y, et al. (2010). Modified hydrolysis kinetics of the active lactone moiety of 10-hydroxycamptothecin by liposomal encapsulation. Pharm Dev Technol 15:644–52.
   PubMed Web of Science ®Google Scholar
• Tian Q, Wang XH, Wang W, et al. (2012). Self-assembly and liver targeting of sulfated chitosan nanoparticles functionalized with glycyrrhetinic acid. Nanomedicine 8:870–9.
   PubMed Web of Science ®Google Scholar
• Wang S, Ye T, Yang B, et al. (2013). 7-Ethyl-10-hydroxycamptothecin proliposomes with a novel preparation method: optimized formulation, characterization and in-vivo evaluation. Drug Develop Ind Pharma 39:393–401.
   PubMed Web of Science ®Google Scholar
• Xie X, Yang Y, Lin W, et al. (2015). Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ultrasound triggered siRNA delivery. Colloids Surf B Biointerf 136:641–50.
   PubMed Web of Science ®Google Scholar
• Xie X, Wen L, Hui L, et al. (2016). Ultrasound-responsive nanobubbles contained with peptide – camptothecin conjugates for targeted drug delivery. Drug Deliv 23:2756–64.
   PubMed Web of Science ®Google Scholar
• Yang J, Ni B, Liu J, et al. (2011). Application of liposome-encapsulated hydroxycamptothecin in the prevention of epidural scar formation in New Zealand white rabbits. Spine J Off J North Am Spine Soc 11:218–23.
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang YF, Xie XY, et al. (2015). Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery. Biomaterials 48:84–96.
   PubMed Web of Science ®Google Scholar
• Ye TT, Wu Y, Shang L, et al. (2018a). Improved lymphatic targeting: effect and mechanism of synthetic borneol on lymph node uptake of 7-ethyl-10-hydroxycamptothecin nanoliposomes following subcutaneous administration. Drug Deliv 25:1461–71.
   PubMed Web of Science ®Google Scholar
• Ye X, Yang X, Wei P, et al. (2018b). N -methylpyrrolidone exfoliated graphene as sensitive electrochemical sensing platform for 10-Hydroxycamptothecine. Electroanal Chem 818:210–5.
   Google Scholar
• Zhang C, Wang W, Liu T, et al. (2012). Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy. Biomaterials 33:2187–96.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang M, Ji J, et al. (2015). Glycyrrhetinic acid-mediated polymeric drug delivery targeting the acidic microenvironment of hepatocellular carcinoma. Pharma Res 32:3376–90.
   Web of Science ®Google Scholar
• Zhu L, Ni B, Liu J, et al. (2013). Hydroxycamptothecin liposomes inhibit collagen secretion and induce fibroblast apoptosis in a postlaminectomy rabbit model. Eur J Orthop Surg Traumatol 23:85–91.
   PubMedGoogle Scholar
• Zhu R, Zhang CG, Liu Y, et al. (2015). CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with α-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells. Sci Rep 5:17904–16.
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhang W, Wang D, et al. (2018). Preparation and characterization of norcantharidin liposomes modified with stearyl glycyrrhetinate. Exp Ther Med 16:1639–46.
   PubMed Web of Science ®Google Scholar